Product Information
SELEGILINE HCL 5 MG TABLET is a generic product labeled by i3 Pharmaceuticals, LLC, priced at $0.7925 per EA under NDC 72319000602. Its NADAC has been published 227 times since Apr 20, 2022.
FDA first approved this application on Apr 1, 1997. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/1
Manufacturer
i3 Pharmaceuticals, LLCNDC
72319000602
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
SELEGILINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA074672FDA Approved
4/1/1997
TE Code
AB
On Market Since
12/15/2021
Pharmacological Classes
Price Statistics
The NADAC for SELEGILINE HCL 5 MG TABLET has been published 227 times since Apr 20, 2022, and over the history we have for it it has declined 21.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7925 per EA |
|---|---|
| All-time high | $1.0975 (Aug 10, 2022) |
| All-time low | $0.6101 (Jul 17, 2024) |
| 52-week high | $0.8788 |
| 52-week low | $0.6895 |
| Median price | $0.8231 |
| Average price | $0.8266 |
| Largest weekly change | +33.5% (May 17, 2023) |
| Weeks tracked | 227 |
| Tracking since | Apr 20, 2022 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 23% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of SELEGILINE HCL 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for SELEGILINE HCL 5 MG TABLET, manufactured by i3 Pharmaceuticals, LLC, is $0.7925 per EA (NDC 72319000602), effective Aug 19, 2026.
How has the price of SELEGILINE HCL 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for SELEGILINE HCL 5 MG TABLET has declined 21.4%. It has been tracked across 227 weekly CMS publications since Apr 20, 2022.
What are the highest and lowest recorded NADAC prices for SELEGILINE HCL 5 MG TABLET?
Since Apr 20, 2022, the NADAC for SELEGILINE HCL 5 MG TABLET has ranged from a low of $0.6101 (Jul 17, 2024) to a high of $1.0975 (Aug 10, 2022), with a median of $0.8231 per EA.
Are there cheaper alternatives to SELEGILINE HCL 5 MG TABLET?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, SELEGILINE HCL 5 MG TABLET, is $0.6101 per EA — about 23% below SELEGILINE HCL 5 MG TABLET.
Who manufactures SELEGILINE HCL 5 MG TABLET?
SELEGILINE HCL 5 MG TABLET (NDC 72319000602) is labeled by i3 Pharmaceuticals, LLC, and CMS classifies it as a generic product.